Senolytic Therapeutics: Translating a Compelling Mouse Phenotype Into a Testable Human Endpoint. Translational Medicine & Therapeutics Journal, [S. l.], v. 2, n. 1, p. 10–18, 2023. DOI: 10.5281/zenodo.22649028. Disponível em: https://inkwise.org/index.php/TMTJ/article/view/78. Acesso em: 5 nov. 2026.